Core Viewpoint - Revelation Biosciences, Inc. has entered into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to 13,065,000 shares of common stock at a reduced exercise price of $0.86 per share [1]. Group 1 - The company is a clinical-stage life sciences firm focused on rebalancing inflammation [1]. - The existing warrants were issued on September 11, 2025 [1]. - The shares of common stock that can be issued upon exercise of the existing warrants are registered under an effective registration statement on Form S-3 [1].